Universe Pharmaceuticals ... (UPC)

0.12

-0.01 (-6.03%)

At close: Mar 03, 2025, 3:59 PM

0.12

5.76%

After-hours: Mar 03, 2025, 07:58 PM EST

Universe Pharmaceuticals INC Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-6.16M	-8.74M	11.32M	7.56M	7.55M	7.6M
Depreciation & Amortization	508.79K	533.95K	446.88K	410.08K	418.43K	452.73K
Stock-Based Compensation	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	1.45M	10.02M	-10.82M	713.52K	-166.52K	-654.88K
Other Non-Cash Items	-526.91K	906.59K	-468.17K	22.71K	112.79K	-85.19K
Deferred Income Tax	679.59K	-605.28K	-668.34K	-9.89K	-39.63K	17.54K
Change in Working Capital	6.62M	6.59M	-12.69M	-1.87M	5.16M	-3.53M
Operating Cash Flow	1.12M	-1.31M	-2.06M	6.12M	13.2M	4.46M
Capital Expenditures	-44.17K	-93.7K	-13.53M	-51.8K	-86.32K	-145.09K
Acquisitions	n/a	-3.81M	26.62M	n/a	291.00	n/a
Purchase of Investments	n/a	n/a	-15.33M	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	1.8M	n/a	n/a	n/a
Other Investing Acitivies	n/a	523.00	-26.62M	n/a	-0.00	n/a
Investing Cash Flow	-44.17K	-3.91M	-27.06M	-51.8K	-86.03K	-145.09K
Debt Repayment	-1.39M	n/a	624.35K	911.2K	1.14K	-1.85M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	-16M	-3.06M
Other Financial Acitivies	n/a	3.32M	-2.79M	-441.06K	n/a	n/a
Financial Cash Flow	-1.39M	3.32M	26.58M	470.14K	-16M	-4.91M
Net Cash Flow	-426.21K	-2.37M	-1.98M	6.88M	-3.01M	-793.24K
Free Cash Flow	1.08M	-1.41M	-15.59M	6.06M	13.12M	4.31M